High treatment modification rates with lamivudine therapy in HBV-infected patients with low baseline viremia and early virological response: A multicenter study

Gonen, Can; Gunduz, FEYZA; Doganay, Levent; Enc, Feruze; Yegin, Ender; Ahishali, Emel; Erdem, Emrullah; Sokmen, Mehmet; TUNCER, İLYAS; Ozdogan, Osman

doi:10.1111/1751-2980.12237

High treatment modification rates with lamivudine therapy in HBV-infected patients with low baseline viremia and early virological response: A multicenter study

Copy For Citation

Gonen C., Gunduz F., Doganay L., Enc F. Y., Yegin E. G., Ahishali E., ...More

JOURNAL OF DIGESTIVE DISEASES, vol.16, no.5, pp.286-292, 2015 (SCI-Expanded)

Publication Type: Article / Article
Volume: 16 Issue: 5
Publication Date: 2015
Doi Number: 10.1111/1751-2980.12237
Journal Name: JOURNAL OF DIGESTIVE DISEASES
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.286-292
Marmara University Affiliated: Yes

Abstract

ObjectiveLow baseline viremia and an early treatment response predict the best outcomes in hepatitis B virus (HBV)-infected patients treated with nucleoside analogues with low barriers to resistance. The aim of this study was to assess the long-term results and effectiveness of lamivudine in patients with low baseline viremia and early virological treatment response.